References
- Ren W, Li W, Wang D, Hu S, Suo J, Ying X. Combining multi-dimensional data to identify key genes and pathways in gastric cancer. Peer J. 2017;5:3385–3302. doi:https://doi.org/10.7717/peerj.3385.
- Wayman J, Forman D, Griffin SM. Monitoring the changing pattern of esophago gastric cancer: data from a UK regional cancer registry. Cancer Causes Control. 2001;12(10):943–949. doi:https://doi.org/10.1023/A:1013756531219.
- Yalçın B, Zengin N, Aydın F, et al. The clinical and pathological features of patients with gastric cancer in Turkey: a Turkish oncology group study. Turkish J Cancer. 2006;36:108–111.
- Alacalı M. Gastric cancer, screening and prevention methods. Ankara Med J. 2012;12:195–198.
- Arnal MJD, Arenas ÁF, Arbeloa ÁL. Esophageal cancer: risk factors, screening and endoscopictreatment in western and eastern countries. WJG. 2015;21(26):7933. doi:https://doi.org/10.3748/wjg.v21.i26.7933.
- Altorki N, Kent M, Ferrara C, Port J. Results of nationwide study on the three field lymph node dissection of esophageal cancer. Oncology. 1991;48:411–420. doi:https://doi.org/10.1097/01.SLA.0000021583.51164.F4.
- Shen GR, Li WZ, Liu YC, Li XP, Yuan HY. Association between a microRNA-214 binding site polymorphism in the methylenetetrahydrofolate reductase gene and esophageal squamous cell carcinoma. Genetic Mol Res. 2016;15:1–6. doi:https://doi.org/10.4238/gmr.15028158.
- Bagley PJ, Selhub J . A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci USA. 1998;95(22):13217–13220. doi:https://doi.org/10.1073/pnas.95.22.13217.
- Dikmen M. Molecular biology of methylenetetrahydrofolate reductase (MTHFR) enzyme and its association with diseases. Med J Kocatepe. 2004;5:9–16.
- Rezende LM, Augusto F, Marson L, Sílvia C, Lima P, Bertuzzo CS. Can MTHFR C677T and A1298C polymorphisms alter the risk and severity of sporadic breast cancer in Brazilian women? Clin Breast Cancer. 2017;1:1–8. doi:https://doi.org/10.1016/j.clbc.2017.02.004.
- Schneider JA, Rees DC, Liu YT, Clegg JB. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet. 1998;62(5):1258–1260. doi:https://doi.org/10.1086/301836.
- Chen L, Lu N, Zhang BH, Weng L, Lu J. Association between the MTHFR C677T polymorphism and gastric cancer susceptibility: A meta-analysis of 5,757 cases and 8,501 controls. Oncol Lett. 2015;10(2):1159–1165. doi:https://doi.org/10.3892/ol.2015.3356.
- Arslan S, Karadayi S, Yildirim ME, Özdemir Ö, Akkurt İ. The association between methylene-tetrahydrofolate reductase gene polymorphism and lung cancer risk. Mol Biol Rep. 2011;38(2):991–996. doi:https://doi.org/10.1007/s11033-010-0194-z.
- Piyathilake CJ, Macaluso M, Johanning GL, Whiteside M, Heimburger DC, Giuliano A. Methylenetetrahydrofolate reductase (MTHFR) polymorphisim increases the risk of cervical intraepithelial neoplasia. Anticancer Res. 2000;20:1751–1757.
- Zhang B, Zhang W, Yan L, Wang D. The association between MTHFR gene C677T polymorphismand ALL risk based on a meta-analysis involving 17,469 subjects. ClinicaChimicaActa. 2017;466:85–82. doi:https://doi.org/10.1016/j.cca.2017.01.001.
- Jiang S, Xu JD, Zhuo ZJ, Hua ZM. Association of MTHFR c677T and a1298c polymorphisms with oral cancer susceptibility: evidence from a meta-analysis. Onco Targets Ther. 2017;10:303–310. doi: https://doi.org/10.2147/OTT.S124690
- Wadhwa R, Song S, Lee JS, Yao Y, Wei Q, Ajani JA . Gastric cancer-molecular and clinical dimensions. Nat Rev Clin Oncol. 2013;10(11):643–655. doi: https://doi.org/10.1038/nrclinonc.2013.170.
- Conteduca V, Sansonno D, Lauletta G, Russi S, Ingravallo G, Dammacco FH. Pylori infection and gastric cancer: state of the art (review). Int J Oncol. 2013;42(1):5–18. doi:https://doi.org/10.3892/ijo.2012.1701.
- Holcombe C. Helicobacter pylori: The African enigma. Gut. 1992;33(4):429–431. doi:https://doi.org/10.1136/gut.33.4.429.
- Mazzuca F, Borro M, Botticelli A, et al. Effect of MTHFR Polymorphisms on gastrointestinal cancer risk in Italy. World J Oncol. 2015;6(4):394–397. doi:https://doi.org/10.14740/wjon930w.
- Wei L, Niu F, Wu J, et al. Association study between genetic polymorphisms in folate metabolism and gastric cancer susceptibility in Chinese Han population: a case control study. Mol Genet Genomic Med. 2019;7(5):e633. doi:https://doi.org/10.1002/mgg3.633.
- Xia LZ, Liu Y, Xu XZ, et al. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility. World J Gastroenterol. 2014;20(32):11429–11438. doi:https://doi.org/10.3748/wjg.v20.i32.11429.
- Kim JK, Kim S, Han JH, et al. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population. Anticancer Res. 2005;25:2249–2252.
- Cui LH, Shin MH, Kweon SS, et al . Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer in a Korean population. BMC Cancer. 2010;10:236–234. doi:https://doi.org/10.1186/1471-2407-10-236.
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D . Global Cancer statistics. CA Cancer J Clin. 2011;61(2):69–79. doi: https://doi.org/10.3322/caac
- Jemal A, Center MM, Desantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1893–1907. doi:https://doi.org/10.1158/1055-9965.EPI-10-0437.
- Islami F, Boffetta P, Ren JS, Pedoeim L, Khatib D, Kamangar F . High-temperature beverages and foods and esophageal cancer risk-a systematic review. Int J Cancer. 2009;125(3):491–524. doi:https://doi.org/10.1002/ijc.24445.
- Engel LS, Chow WH, Vaughan TL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95(18):1404–1413. doi:https://doi.org/10.1093/jnci/djg047.
- Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr. 2000;130(2):129–132. doi:https://doi.org/10.1093/jn/130.2.129.
- Ye B, Feng J, Pan X, et al. Genetic variant of single-nucleotide polymorphism is associated with risk of esophageal squamous cell carcinoma. Genet Test Mol Biomarkers. 2014;18(1):45–49. doi:https://doi.org/10.1089/gtmb.2013.0336.
- Rachael Z, Solomon S, Qiao YL, et al. Esophageal and gastric cardia cancer risk and Folate- and Vitamin B12-related polymorphisms in Linxian, China. Cancer Epidemiol Biomark Prevent. 2003;12:1222–1226.
- Pan D, Su M, Huang G, et al . MTHFR C677T genetic polymorphism in combination with serum vitamin B2, B12 and aberrant DNA methylation of P16 and P53 genes in esophageal squamous cell carcinoma and esophageal precancerous lesions: a case-control study. Cancer Cell Int. 2019;19:288–280. doi:https://doi.org/10.1186/s12935-019-1012-x.
- Linnebank M, Semmler A, Moskau S, Smulders Y, Blom H, Simon M . The methylenetetrahydrofolate reductase (MTHFR) variant c.677C > T (A222V) influences overall survival of patients with glioblastoma multiforme. Neuro-oncology. 2008;10(4):548–552. doi:https://doi.org/10.1215/15228517-2008-020.
- Zhao T, Gu D, Xu Z, et al. Polymorphism in one-carbon metabolism pathway affects survival of gastric cancer patients: large and comprehensive study. Oncotarget. 2015;6(11):9564–9576. doi:https://doi.org/10.18632/oncotarget.3259.